Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
46.16 CHF | +0.35% |
|
-4.43% | -37.46% |
07-17 | DOCMORRIS : Warburg Research reaffirms its Buy rating | ZD |
07-12 | DOCMORRIS : Hauck & Aufhauser reaffirms its Buy rating | ZD |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.46% | 670M | |
-54.62% | 10.23B | |
-45.52% | 8.86B | |
-20.05% | 7.04B | |
-1.14% | 6.45B | |
+93.90% | 5.28B | |
-2.48% | 4.63B | |
+4.58% | 4.45B | |
-31.43% | 3.82B | |
+7.60% | 3.1B |
- Stock Market
- Equities
- ROSE Stock
- News DocMorris AG
- Zur Rose Group Ag Announces Sales Results for the Fourth Quarter and Year Ended December 31, 2017